RIPE-KG · Version 1.1.0 · Resource
ripekg:work/10.1016%2Fj.ahj.2011.06.019
https://w3id.org/ripe/ripe-kg/work/10.1016%2Fj.ahj.2011.06.019
| Subject | Predicate | Object |
|---|---|---|
ripekg:work/10.1016%2Fj.ahj.2011.06.019Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging |
prism:doi |
10.1016/j.ahj.2011.06.019 |
ripekg:work/10.1016%2Fj.ahj.2011.06.019Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging |
dcterms:title |
Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging |
ripekg:work/10.1016%2Fj.ahj.2011.06.019Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging |
rdf:type |
node1 |
ripekg:work/10.1016%2Fj.ahj.2011.06.019Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/10.1016%2Fj.ahj.2011.06.019Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging |
rdf:type |
rdfs:Resource |
ripekg:work/10.1016%2Fj.ahj.2011.06.019Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging |
rdf:type |
owl:Thing |
ripekg:work/10.1016%2Fj.ahj.2011.06.019Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging |
rdf:type |
prov:Entity |
ripekg:work/10.1016%2Fj.ahj.2011.06.019Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging |
rdf:type |
ripe:WorkWork |
ripekg:work/10.1016%2Fj.ahj.2011.06.019Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging |
owl:sameAs |
https://semopenalex.org/work/W21982659 |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1016%2Fj.ahj.2011.06.019Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1016%2Fj.ahj.2011.06.019Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging |